Affiance Financial’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $933K | Hold |
13,206
| – | – | 0.13% | 59 |
|
|
2026
Q1 | $690K | Sell |
13,206
-1,633
| -11% | -$98K | 0.11% | 62 |
|
|
2025
Q4 | $873K | Hold |
14,839
| – | – | 0.14% | 56 |
|
|
2025
Q3 | $825K | Hold |
14,839
| – | – | 0.15% | 58 |
|
|
2025
Q2 | $763K | Sell |
14,839
-1,867
| -11% | -$93.8K | 0.16% | 56 |
|
|
2025
Q1 | $979K | Sell |
16,706
-1,664
| -9% | -$113K | 0.23% | 48 |
|
|
2024
Q4 | $1.32M | Sell |
18,370
-125
| -0.7% | -$9.18K | 0.32% | 45 |
|
|
2024
Q3 | $1.48M | Sell |
18,495
-1,336
| -7% | -$100K | 0.36% | 43 |
|
|
2024
Q2 | $1.42M | Sell |
19,831
-595
| -3% | -$43.8K | 0.37% | 42 |
|
|
2024
Q1 | $1.44M | Sell |
20,426
-1,652
| -7% | -$118K | 0.39% | 36 |
|
|
2023
Q4 | $1.7M | Sell |
22,078
-150
| -0.7% | -$9.88K | 0.5% | 32 |
|
|
2023
Q3 | $1.51M | Hold |
22,228
| – | – | 0.77% | 29 |
|
|
2023
Q2 | $1.81M | Hold |
22,228
| – | – | 0.88% | 22 |
|
|
2023
Q1 | $1.65M | Sell |
22,228
-2,679
| -11% | -$206K | 0.87% | 24 |
|
|
2022
Q4 | $2.06M | Sell |
24,907
-125
| -0.5% | -$9.93K | 0.84% | 22 |
|
|
2022
Q3 | $1.78M | Hold |
25,032
| – | – | 1% | 16 |
|
|
2022
Q2 | $2.17M | Hold |
25,032
| – | – | 1.17% | 14 |
|
|
2022
Q1 | $2.71M | Sell |
25,032
-1,892
| -7% | -$195K | 1.32% | 14 |
|
|
2021
Q4 | $3.48M | Sell |
26,924
-80
| -0.3% | -$9.81K | 1.45% | 15 |
|
|
2021
Q3 | $3.27M | Hold |
27,004
| – | – | 1.42% | 15 |
|
|
2021
Q2 | $3.04M | Sell |
27,004
-148
| -0.5% | -$15.6K | 1.29% | 15 |
|
|
2021
Q1 | $2.59M | Sell |
27,152
-2,336
| -8% | -$213K | 1.16% | 17 |
|
|
2020
Q4 | $2.34M | Sell |
29,488
-264
| -0.9% | -$19.1K | 1.22% | 15 |
|
|
2020
Q3 | $1.84M | Sell |
29,752
-736
| -2% | -$47.9K | 1.06% | 19 |
|
|
2020
Q2 | $2.01M | Sell |
30,488
-120
| -0.4% | -$7.19K | 1.09% | 16 |
|
|
2020
Q1 | $1.45M | Sell |
30,608
-3,732
| -11% | -$187K | 1% | 19 |
|
|
2019
Q4 | $1.88M | Hold |
34,340
| – | – | 1.04% | 16 |
|
|
2019
Q3 | $1.68M | Hold |
34,340
| – | – | 1.02% | 18 |
|
|
2019
Q2 | $1.79M | Sell |
34,340
-5,436
| -14% | -$274K | 1.09% | 17 |
|
|
2019
Q1 | $1.97M | Hold |
39,776
| – | – | 1.24% | 16 |
|
|
2018
Q4 | $1.44M | Hold |
39,776
| – | – | 0.95% | 24 |
|
|
2018
Q3 | $2.03M | Hold |
39,776
| – | – | 1.34% | 14 |
|
|
2018
Q2 | $1.47M | Buy |
+39,776
| New | +$1.52M | 1.12% | 16 |
|
Other funds holding TECH
HI
Affiance Financial's TECH Position: Q2 2026 in Review
Affiance Financial held its Bio-Techne (TECH) position steady in Q2 2026 at 13,206 shares worth $933K. The position accounts for 0.13% of the portfolio, ranked #59.
Affiance Financial first reported a position in TECH in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.48M in Q4 2021. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Affiance Financial held 13,206 shares of Bio-Techne worth $933K as of Q2 2026.
- Affiance Financial left its Bio-Techne share count unchanged in Q2 2026.
- Bio-Techne made up 0.13% of Affiance Financial's portfolio in Q2 2026, its #59 holding.
- Affiance Financial first reported a position in Bio-Techne in Q2 2018 and has held it in 33 quarters since.
- Affiance Financial's Bio-Techne position peaked at $3.48M in Q4 2021.
- 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Affiance Financial's 13F filing for Q2 2026, filed 9 Jul 2026.